⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4455224 | 0.75 | — | — | |
| SCHEMBL4689155 | 0.75 | — | — | |
| SCHEMBL3630273 | 0.69 | — | — | |
| SCHEMBL16345253 | 0.69 | — | — | |
| SCHEMBL1431505 | 0.67 | — | — | |
| SCHEMBL6426565 | 0.66 | — | — | |
| SCHEMBL2814142 | 0.63 | — | — | |
| SCHEMBL17698978 | 0.62 | — | — | |
| SCHEMBL1501235 | 0.62 | — | — | |
| SCHEMBL6689824 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090312414-A1 | Treatment Of Lower Urinary Tract Dysfunction With CB2-Receptor-Selective Agonists | THE PROCTER & GAMBLE COMPANY (US) | 2009-12-17 | — | — | US | disclosed |
| WO-2009140078-A1 | TREATMENT OF LOWER URINARY TRACT DYSFUNCTION WITH CB2-RECEPTOR-SELECTIVE AGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 2009-11-19 | — | — | WO | disclosed |